Skip to main content

26 April 2023 - The antimicrobial potential of bacteriophages - Oral evidence

Committee Science, Innovation and Technology Committee
Inquiry The antimicrobial potential of bacteriophages

Wednesday 26 April 2023

Start times: 9:20am (private) 9:30am (public)


Add to calendar

MPs to examine the role of bacteria-killing viruses in the UK’s antimicrobial resistance strategy

Leading medical and health bodies will be questioned by MPs on the role of phages in the UK’s antimicrobial resistance (AMR) strategy. Phages are ‘good’ viruses that can target and kill harmful bacteria. They are mentioned in the strategy as a promising tool to tackle the growing levels of antibiotic resistant disease.

Meeting details

At 9:30am: Oral evidence
Inquiry The antimicrobial potential of bacteriophages
Head of Infectious Disease Interventions at Wellcome Trust
Director of Strategy and Planning at Medical Research Council
Director Health and Life Sciences at Innovate UK
At 10:15am: Oral evidence
Inquiry The antimicrobial potential of bacteriophages
Scientific Officer at UK Health Security Agency
Scientific Leader in Healthcare Biotechnology at UK Health Security Agency
Chief Science, Research & Innovation Officer at Medicines and Healthcare products Regulatory Agency
At 11:00am: Oral evidence
Inquiry The antimicrobial potential of bacteriophages
Deputy Director for UK Health Security at Department for Health and Social Care

Previous witnesses to the inquiry have suggested the UK is behind other countries in developing phages due to regulatory barriers.

The third session of the Commons Science and Technology Committee’s inquiry will focus on the UK’s funding of phage research and regulation of phages. MPs will then put questions to the UK Health Security Agency, the medical regulator MHRA and Department of Health.

The inquiry is the result of the successful pitch to the Committee’s My Science Inquiry.

Location

Room 15, Palace of Westminster

How to attend